[Top] [All Lists]

[e-drug] New Book: Equitable access to high cost pharmaceuticals

E-DRUG: New Book: Equitable access to high cost pharmaceuticals

Dear E-druggers

I would like to introduce you to recently published book on access to high-cost 
medicines. The book can be  accessed if you have an institutional subscription 
to science direct database.

Book information

Equitable Access to High-Cost Pharmaceuticals
Editor: Zaheer-Ud-Din Babar
Paperback ISBN: 9780128119457
Imprint: Academic Press
Published Date: 21st February 2018
Page Count: 238

Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and 
implementation of equitable public health policies by pharmaco-economics 
professionals, health economists, and policymakers. With detailed country-by 
country analysis of policy and regulation, the Work compares and contrasts 
national healthcare systems to support researchers and practitioners identify 
optimal healthcare policy solutions. The Work incorporates chapters on global 
regulatory changes, health technology assessment guidelines, and competitive 
effectiveness research recommendations from international bodies such as the 
OECD or the EU. Novel policies such as horizon scanning, managed-entry 
agreement and post-launch monitoring are considered in detail. The Work also 
thoroughly reviews novel pharmaceuticals with particular research interest, 
including cancer drugs, orphan medicines, Hep C, and personalized medicines.

"Equitable Access to High-Cost Pharmaceuticals forms an all-inclusive source of 
knowledge for understanding the issues surrounding access to and cost of new 
medicines by merging theory with practice, providing a comprehensive outlook on 
pharmaceutical policy and regulation challenges." — Aris Angelis, The London 
School of Economics and Political Science


Chapter 1
Access to High-Cost Medicines: An Overview
Syed Shahzad Hasan, Christine Y. Lu, Zaheer-Ud-Din Babar

Chapter 2
Health Technology Assessment
Jennifer A. Whitty

Chapter 3
High-Cost Medicines in England
Darrin Baines

Chapter 4
Managed Entry Agreements and High-Cost Medicines (European Perspective)
Claudio Jommi

Chapter 5
Setting a Public Health Agenda to Support Access to High-Cost Medicines
Inthira Yamabhai

Chapter 6
Human Rights and Intellectual Property for Universal Access to New Essential 
Katrina Perehudoff, Ellen ’t Hoen

Chapter 7
Access to High Price Medicines in Portugal
Filipa Alves da Costa, Ana Paula Martins

Chapter 8
Improving Access to High-Cost Medicines in Low Income Countries in Africa: 
Creating a Functioning Pharmaceutical System in Uganda
Brendan Kwesiga, Anita Katharina Wagner, Morries Seru,Birna Trap

Chapter 9
Equitable Access to Biosimilars: An Overview
Khurram Rehman, Nadeem Irfan Bukhari, Zaheer-Ud-Din Babar

Chapter 10
Access to High-Cost Medicines in Europe
Sabine Vogler

Chapter 11
Access to High-Cost Medicines in Australia
Agnes Isabelle Vitry, Russell Shute

Chapter 12
Access to High-Cost Medicines in New Zealand
Louise E. Curley, Maree Jensen, Zaheer-Ud-Din Babar,
Sanya Ram

Chapter 13
Access to High-Cost Medicines in Wales
Alice Varnava, Sabrina Rind, Robert Bracchi, Karen Samuels, Philip A. 
Routledge, Dyfrig A. Hughes

Kind Regards

Zaheer-Ud-Din Babar, PhD
Professor in Medicines and Healthcare
Department of Pharmacy, University of Huddersfield, Queensgate, HD1 3DH
Huddersfield, United Kingdom
Zaheer Babar <Z.Babar@hud.ac.uk>

<Prev in Thread] Current Thread [Next in Thread>
  • [e-drug] New Book: Equitable access to high cost pharmaceuticals, Zaheer Babar <=